Only approximately 10% of non-synonymous tumor cell mutations generate mutant peptides with high MHC affinity and only 1% of MHC-binding peptides are recognized by patient T cells according to DNA sequencing [33, 34]. This evidence concerns the gene HLA-C and neoplasm.